Skip to main content
. 2021 Jan 2;100(2):465–479. doi: 10.1007/s00277-020-04387-7

Fig. 2.

Fig. 2

Forest plot of the pooled HRs and 95% CIs assessing the prognostic value of ASXL1 mutations in patients with PMF. a For OS by a random-effects model. b For LFS by a fixed-effects model. c For the rate of acute leukocyte transformation by a fixed-effects model. Number sign, one cohort of the study; single asterisk, another cohort of the study; double number sign, British Journal of Haematology; double asterisk, Leukemia